3-Hydroxy-L-(2,5,6-2H3)tyrosine

Modify Date: 2024-01-23 19:26:58

3-Hydroxy-L-(2,5,6-2H3)tyrosine Structure
3-Hydroxy-L-(2,5,6-2H3)tyrosine structure
Common Name 3-Hydroxy-L-(2,5,6-2H3)tyrosine
CAS Number 53587-29-4 Molecular Weight 200.20600
Density 1.49g/cm3 Boiling Point 448.4ºC at 760 mmHg
Molecular Formula C9H8D3NO4 Melting Point 292ºC (dec.)(lit.)
MSDS Chinese USA Flash Point 225ºC
Symbol GHS07
GHS07
Signal Word Warning

 Use of 3-Hydroxy-L-(2,5,6-2H3)tyrosine


L-DOPA-2,5,6-d3 (Levodopa-2,5,6-d3) is the deuterium labeled L-DOPA. L-DOPA (Levodopa) is an orally active metabolic precursor of neurotransmitters dopamine. L-DOPA can cross the blood-brain barrier and is converted into dopamine in the brain[1][2][3].

 Names

Name (2S)-2-amino-3-(2,3,6-trideuterio-4,5-dihydroxyphenyl)propanoic acid
Synonym More Synonyms

 3-Hydroxy-L-(2,5,6-2H3)tyrosine Biological Activity

Description L-DOPA-2,5,6-d3 (Levodopa-2,5,6-d3) is the deuterium labeled L-DOPA. L-DOPA (Levodopa) is an orally active metabolic precursor of neurotransmitters dopamine. L-DOPA can cross the blood-brain barrier and is converted into dopamine in the brain[1][2][3].
Related Catalog
In Vitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

[2]. Hyland K, et al. Aromatic L-amino acid decarboxylase deficiency: diagnostic methodology. Clin Chem. 1992 Dec;38(12):2405-10.

[3]. Merims D, et al. Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease. Parkinsonism Relat Disord. 2008;14(4):273-80. Epub 2007 Nov 7.

[4]. Perez-Pardo P, et al. Additive Effects of Levodopa and a Neurorestorative Diet in a Mouse Model of Parkinson's Disease. Front Aging Neurosci. 2018 Aug 3;10:237.

[5]. Park HJ, et al. Anti-allodynic effects of levodopa in neuropathic rats. Yonsei Med J. 2013 Mar 1;54(2):330-5.

 Chemical & Physical Properties

Density 1.49g/cm3
Boiling Point 448.4ºC at 760 mmHg
Melting Point 292ºC (dec.)(lit.)
Molecular Formula C9H8D3NO4
Molecular Weight 200.20600
Flash Point 225ºC
Exact Mass 200.08800
PSA 103.78000
LogP 0.75250
Index of Refraction 1.654

 Safety Information

Symbol GHS07
GHS07
Signal Word Warning
Hazard Statements H302-H315-H319-H335
Precautionary Statements P261-P305 + P351 + P338
Personal Protective Equipment dust mask type N95 (US);Eyeshields;Gloves
Hazard Codes Xn
Risk Phrases R22
Safety Phrases 26-36
RIDADR NONH for all modes of transport

 Articles2

More Articles
Restriction of dopamine signaling to the dorsolateral striatum is sufficient for many cognitive behaviors.

Proc. Natl. Acad. Sci. U. S. A. 106(34) , 14664-9, (2009)

The striatum is a vital substrate for performance, procedural memory, and learning. The ventral and medial striatum are thought to be critical for acquisition of tasks while the dorsolateral striatum ...

Capsules from pathogenic and non-pathogenic Cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cells.

PLoS ONE 7 , e29561, (2012)

Capsule production is common among bacterial species, but relatively rare in eukaryotic microorganisms. Members of the fungal Cryptococcus genus are known to produce capsules, which are major determin...

 Synonyms

L-DOPA-2,5,6-d3
L-Tyrosine-2,5,6-d, 3-hydroxy-
Dopa-phenyl-d3
MFCD00075014
L-Dihydroxyphenylalanine-2H3
3-Hydroxy-L-(2,5,6-H)tyrosine
2,3,6-trideuterio-4,5-dihydroxy-phenylalanine